Medical Tubing Market - Growth Drivers and Challenges
Growth Drivers
- Rising government healthcare spending via Medicare and Medicaid: The government programs nowadays are actively investing in medical devices, including tubing systems for both home-based treatments and in hospitals. As per Medicare, spending on catheter-based care and infusion therapies increased to USD 2.6 billion in 2023, with the catheter expenses alone growing 11.3% every year, impacting the broader applications in chronic disease management. A greater variety of items connected to tubing are now included by reimbursement codes under the Healthcare Common Procedure Coding System (HCPCS).
- Healthcare quality improvement initiatives: A 2022 AHRQ study showed that widespread use of sterile, disposable medical tubing in U.S. acute care facilities decreased CLABSIs by 28.4%, saving an estimated USD 472.6 million on national hospitalization expenditures during two years. Such evidence supports increased procurement of good-quality tubing systems in quality improvement initiatives. This minimization in cost has led to a 19.2% decrease in ICU stay period, focusing on the clinical efficiency of advanced tubing systems.
Historical Patient Growth & Its Impact on Market Dynamics
Historical Patient Growth (2010-2020) in Key Markets
|
Country |
Patients (2010) |
Patients (2020) |
% Growth (2010–2020) |
|
U.S. |
21.9 million |
30.2 million |
+38.9% |
|
Germany |
6.1million |
7.9 million |
+28.1% |
|
France |
4.5 million |
5.8 million |
+31.2% |
|
Spain |
3.5 million |
4.7 million |
+35.8% |
|
Australia |
2.4 million |
3.0 million |
+42.4% |
|
Japan |
9.9 million |
12.8 million |
+30.8% |
|
India |
11.7 million |
18.9 million |
+63.2% |
|
China |
25.9 million |
42.6 million |
+64.9% |
|
Country |
Expansion Model |
Revenue Growth (%) |
Key Approach |
|
India |
Public-private partnerships with NHM hospitals |
+12.4% |
State-level device procurement model |
|
U.S. |
Medicare-driven device reimbursements |
+9.7% |
Local tubing assembly & CMS-backed expansion |
|
Germany |
Sustainable material compliance in hospital procurement |
+8.1% |
ESG-focused manufacturing and supply agreements |
|
China |
Regional distributor bundling with provincial hospitals |
+14.5% |
Volume-based local tenders and tax incentives |
|
France |
Hospital-university partnerships for R&D tubing products |
+8.7% |
Academic-medical innovation consortiums |
Challenges
- Government-imposed pricing caps and budgetary constraints: In Europe, the national healthcare systems impose a robust price ceiling to contain expenditures. For example, the national health procurement authority in France restricted single-use medical device price increases to less than 2.5% YoY, which constrained supplier profitability. On the other hand, Germany’s G-DRG hospital payment system enforces bundled payment models, manufacturing high-quality tubing options with less financially attractive and funded by insurers.
Medical Tubing Market Size and Forecast:
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.1% |
|
Base Year Market Size (2024) |
USD 10.1 billion |
|
Forecast Year Market Size (2037) |
USD 21.7 billion |
|
Regional Scope |
|